Award recognizes his collaborative work in neuroscience and neuroinformatics
Neuroscientist Alan Evans has been awarded the Killam Prize, one of Canada’s highest honours, for his numerous contributions to the understanding of the human brain.
Evans is an internationally recognized researcher at The Neuro (Montreal Neurological Institute-Hospital), James McGill Professor in Neurology and Neurosurgery and the Victor Dahdaleh Chair in Neurosciences.
The Neuro proudly supports the Open COVID Pledge, which calls on academic institutions, industry, and other organizations to make their intellectual property available free of charge for use in ending the COVID-19 pandemic and minimizing its impact.
Montreal medical specialists and 3D printing company team up to find solutions for critical supply shortages
The COVID-19 pandemic has created an unprecedented need to provide personal protective equipment (PPE) for hospital staff. A team of Montreal medical experts has partnered with a 3D printing company to design and distribute face shields to protect healthcare workers as they treat patients with this life-threatening disease.
The Neuro’s director has been a driving force in neurological disease research and Open Science leadership
Study suggests humans have developed complementary neural systems in each hemisphere for auditory stimuli
Speech and music are two fundamentally human activities that are decoded in different brain hemispheres. A new study used a unique approach to reveal why this specialization exists.
Open source app helps predict brain tumour malignancy and patient survival
The power of artificial intelligence (AI) in medicine lies in its ability to find important statistical patterns in large datasets. A study published today is an important proof of concept for how AI can help doctors and brain tumour patients make better treatment decisions.
New technique could be used to choose best therapies for patients and measure their effectiveness
Evaluating the effectiveness of therapies for neurodegenerative diseases is often difficult because each patient’s progression is different. A new study shows artificial intelligence (AI) analysis of blood samples can predict and explain disease progression, which could one day help doctors choose more appropriate and effective treatments for patients.
Q1K: A collaborative undertaking involving 1,000 families to transform autism care
Food can trigger overconsumption similar to alcohol and drugs, but it is not the whole story
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs. But obesity is also a complex condition that cannot be fully explained by the addiction model.
Technique can be used to better categorize patients with neurological disease, according to their therapeutic needs
Personalized medicine – delivering therapies specially tailored to a patient’s unique physiology – has been a goal of researchers and doctors for a long time. New research provides a way of delivering personalized treatments to patients with neurological disease.
Multiple events planned for this week will help educate the public about amyotrophic lateral sclerosis (ALS), a devastating disease that still has no cure.
When NHL star player Sidney Crosby suffered a concussion during a game in May – the fourth concussion of his career – the news made nationwide headlines. A few years earlier, a concussion had kept the Pittsburgh Penguins star off the ice for ten months.
The Montreal Neurological Institute and Hospital (The Neuro) is recognized worldwide for its research and clinical expertise in Parkinson’s disease (PD). PD is a motor neuron disease that is generally associated with old age, but people can also develop it in their thirties and forties.
In an article published in Nature on Feb. 15, 2017, researchers, including principal investigators from the Montreal Neurological Institute’s McConnell Brain Imaging Centre (BIC), used magnetic resonance imaging (MRI) to predict the development of autism in babies.